Related Experiment Video
Updated: Aug 5, 2026
07:41
A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
Pro-apoptotic interactions between XK469 and the peripheral benzodiazepine receptor
1Departments of Pharmacology and Medicine, Wayne State University School of Medicine, Detroit MI 48201, USA. dhkessel@med.wayne.edu
Cancer Letters
|June 19, 2001
Summary
The anti-tumor agent XK469 shows significant activity against drug-resistant cells. Its R(+) form is more potent than the S(-) form, with cytotoxicity linked to peripheral benzodiazepine receptor binding.
Area of Science:
- Oncology
- Pharmacology
- Molecular Biology
Background:
- Drug resistance is a major challenge in cancer therapy.
- Novel anti-tumor agents are needed to overcome resistance.
- Peripheral benzodiazepine receptors are implicated in cellular processes.
Purpose of the Study:
- To evaluate the anti-tumor activity of XK469 against drug-resistant cell lines.
- To investigate the stereospecificity of XK469's cytotoxic effects.
- To explore the relationship between XK469, apoptosis, and peripheral benzodiazepine receptor binding.
Main Methods:
- In vitro culture of murine leukemia L1210 cells.
- Cytotoxicity assays comparing R(+) and S(-) enantiomers of XK469.
- Assessment of apoptosis induction.
- Correlation analysis with peripheral benzodiazepine receptor binding.
Main Results:
- XK469 demonstrated substantial anti-tumor activity against drug-resistant cell lines.
- The R(+) enantiomer of XK469 was significantly more cytotoxic than the S(-) enantiomer.
- Cytotoxicity was associated with apoptosis induction.
- Drug binding to the peripheral benzodiazepine receptor correlated with cytotoxic response.
Conclusions:
- XK469 is a promising anti-tumor agent with stereospecific activity.
- Peripheral benzodiazepine receptor binding may mediate XK469-induced cytotoxicity.
- Further research into this mechanism could lead to new therapeutic strategies.
Related Concept Videos
01:17The Extrinsic Apoptotic Pathway
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
01:31The Intrinsic Apoptotic Pathway
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:28Drug-Receptor Interaction: Antagonist
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...